Long-term follow-up of acute lymphoblastic leukemia in young children treated by the SCMC-ALL-2009 protocol

References

• Goldberg JM, Silverman LB, Levy DE, et al. Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. JCO. 2003;21(19):3616–3622.
   PubMed Web of Science ®Google Scholar
• Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354(2):166–178.
   PubMed Web of Science ®Google Scholar
• Pui CH, Pei D, Coustan-Smith E, et al. Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study. Lancet Oncol. 2015;16(4):465–474.
   PubMed Web of Science ®Google Scholar
• Tang Y, Xu X, Song H, et al. Long-term outcome of childhood acute lymphoblastic leukemia treated in China. Pediatr Blood Cancer. 2008;51(3):380–386.
   PubMed Web of Science ®Google Scholar
• Liang Y, Yang LH, Jiang H, et al. Treatment outcome of young children with acute lymphoblastic leukaemia: achievements and directions implied from Shanghai Children's Medical Centre based SCMC-ALL-2005 protocol. Br J Haematol. 2015;169(2):267–277.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Hong D, Lu J, et al. Pediatric medical care system in China has significantly reduced abandonment of acute lymphoblastic leukemia treatment. J Pediatr Hematol Oncol. 2015;37(3):181–184.
   PubMed Web of Science ®Google Scholar
• Cai JY, Wang NL, Jiang H, et al. Long-term results of multicenter study based on childhood acute lymphoblastic leukemia 2005 protocol. ZhonghuaErKeZaZhi. 2018;56(7):511–517. [Article in Chinese]
   Google Scholar
• Shen S, Cai J, Chen J, et al. Long-term results of the risk-stratified treatment of childhood acute lymphoblastic leukemia in China. Hematol Oncol. 2018;36(4):679–688.
   PubMed Web of Science ®Google Scholar
• Pieters R, Schrappe M, De Lorenzo P, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomized trial. Lancet. 2007;370(9583):240–250.
   PubMed Web of Science ®Google Scholar
• Koh K, Tomizawa D, Moriya Saito A, et al. Early use of allogeneic hematopoietic stem cell transplantation for infants with MLL gene-rearrangement-positive acute lymphoblastic leukemia. Leukemia. 2015;29(2):290–296.
   PubMed Web of Science ®Google Scholar
• Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the Children’s Oncology Group. JCO. 2012; 30(14):1663–1669.
   PubMed Web of Science ®Google Scholar
• Moricke A, Zimmerman M, Reiter A, et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM group 1981 to 2000. Leukemia. 2010;24(2):265–284.
   PubMed Web of Science ®Google Scholar
• Salzer WL, Devidas M, Carroll WL, et al. Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984–2001: a report from the children's oncology group. Oncology Group Leukemia. 2010;24(2):355–370.
   PubMed Web of Science ®Google Scholar
• Pui CH, Carroll WL, Meshinchi S, et al. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol. 2011;29(5):551–565.
   PubMed Web of Science ®Google Scholar
• Roberts KG, Mullighan CG. Genomics in acute lymphoblastic leukaemia: insights and treatment implications. Nat Rev Clin Oncol. 2015;12(6):344–357.
   PubMed Web of Science ®Google Scholar
• Iacobucci I, Wen J, Meggendorfer M, et al. Genomic subtyping and therapeutic targeting of acute erythroleukemia. Nat Genet. 2019;51(4):694–704.
   PubMed Web of Science ®Google Scholar
• Mann G, Attarbaschi A, Schrappe M, et al. Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study. Blood. 2010;116(15):2644–2650.
   PubMed Web of Science ®Google Scholar
• Adamson PC. Improving the outcome for children with cancer: development of targeted new agents. CA Cancer J Clin. 2015;65(3):212–220.
   PubMed Web of Science ®Google Scholar
• Zawitkowska J, Lejman M, Zaucha-Prażmo A, et al. Clinical characteristics and analysis of treatment result in children with Ph-positive acute lymphoblastic leukaemia in Poland between 2005 and 2017. Eur J Haematol. 2018;101(4):542–548.
   PubMed Web of Science ®Google Scholar
• Slayton WB, Schultz KR, Kairalla JA, et al. Dasatinib plus intensive chemotherapy in children, adolescents, and young adults with Philadelphia chromosome-positive acute lymphoblastic leukemia: results of Children's Oncology Group Trial AALL0622. J Clin Oncol. 2018;36(22):2306–2314.
   PubMed Web of Science ®Google Scholar
• Kruth KA, Fang M, Shelton DN, et al. Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia. Blood. 2017;129(22):3000–3008.
   PubMed Web of Science ®Google Scholar
• Sun X, Fang M, Guan Y, et al. Changes of glucocorticoid receptor isoforms expression in acute lymphoblastic leukemia correlate with glucocorticoid resistance. Pharmazie. 2015;70(5):316–321.
   PubMed Web of Science ®Google Scholar
• Samuels AL, Heng JY, Beesley AH, et al. Bioenergetic modulation overcomes glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia. Br J Haematol. 2014;165(1):57–66.
   PubMed Web of Science ®Google Scholar
• Pui CH, Yang JJ, Hunger SP, et al. Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol. 2015; 33(27):2938–2948.
   PubMed Web of Science ®Google Scholar
• Marjerrison S, Antillon F, Fu L, et al. Outcome of children treated for relapsed acute lymphoblastic leukemia in Central America. Cancer. 2013;119(6):1277–1283.
   PubMed Web of Science ®Google Scholar
• Bhojwani D, Pui CH. Relapsed childhood acute lymphoblastic leukaemia. Lancet Oncol. 2013;14(6):205–217.
   PubMed Web of Science ®Google Scholar
• Mulrooney DA, Hyun G, Ness KK, et al. The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study. Lancet Haematol. 2019;6(6):306–316.
   PubMed Web of Science ®Google Scholar
• Burke MJ, Lamba JK, Pounds S, et al. A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia. Am J Hematol. 2014;89(9):889–895.
   PubMed Web of Science ®Google Scholar
• Heymach J, Krilov L, Alberg A, et al. Clinical cancer advances 2018: annual report on progress against cancer from the American Society of Clinical Oncology. J Clin Oncol. 2018;36(10):1020–1044.
   PubMed Web of Science ®Google Scholar